Skip to main navigation Skip to search Skip to main content

Novel sulfonamide series of qr2 inhibitors to tackle oxidative stress and cognitive decline

Research output: Patent

Abstract

The present invention provides an aromatic sulfonamide-based compound, a pharmaceutical composition comprising same, and methods of using same, such as for inhibiting quinone reductase 2 (QR2) or treating a QR2-related disease or disorder.
Original languageEnglish
Patent number284,840
IPCUS18
Filing date30/03/26
StatePublished - 11 Jul 2024

Fingerprint

Dive into the research topics of 'Novel sulfonamide series of qr2 inhibitors to tackle oxidative stress and cognitive decline'. Together they form a unique fingerprint.

Cite this